Search results
Christopher Ott, PhD. Principal Investigator, Massachusetts General Hospital. Center for Cancer Research. Assistant Professor, Harvard Medical School. Associate Member, Broad Institute. Director, MGH Center for Molecular Therapeutics. christopher [dot]ott [at]mgh [dot]harvard [edu]
- Support
Biomedical research is expensive. We are tremendously...
- Publications
Ott CJ, Blackledge NP, Kerschner JL, Leir S-H, Crawford GE,...
- Our Science
The Ott Laboratory is dedicated to discovering the control...
- Support
In Brief. Analyzing integrative enhancer profiles and transcription factor dependencies, Ott et al. construct enhancer-based core regulatory circuits of chronic lymphocytic leukemia (CLL) and reveal a dominant and essential role for PAX5. BET inhibition disrupts CLL super enhancer networks and suppresses CLL growth. Cancer Cell.
- 2MB
- 22
Prof. Christopher Ott (Mass General Hospital) - Chemical degraders of CBP and p300Ott lab: https://ottlab.org/About Dana-Farber Targeted Protein Degradation ...
- 26 min
- 828
- Dana-Farber TPD
Multiple myeloma is caused by faulty activation of growth genes. In this project, Christopher Ott aims to develop new therapeutics that target the factors driving this malfunctioning expression. He and his group will develop tools to study the myeloma epigenome and to nominate new strategies for drug development.
A customer-focussed Supply Chain, Inventory Management/Planning and Business Development expert with nearly 20 years of sales and operational excellence leading successful teams, projects and integrations in North America (NA). A trusted leader with proven experience coaching and mentoring teams to achieve day-to-day success and providing long-term strategic direction based on KPIs and service ...
- 500+
- 1K
Senior Engineer · Experience: Audi of America · Location: Mountain View · 302 connections on LinkedIn. View Christoph Ott’s profile on LinkedIn, a professional community of 1 billion members.
- Audi of America
Chen Y, Ott CJ, Townsend K, Subbaiah P, Aiyar A, Miller WM. Cholesterol Supplementation During Production Increases the Infectivity of Retroviral and Lentiviral Vectors Pseudotyped with the Vesicular Stomatitis Virus Glycoprotein (VSV-G). Biochem. Eng. J. 2009; 44:199-207. PubMed; Ott CJ, Suszko M, Blackledge NP, Wright JE, Crawford GE, Harris A.
